Michael R. Bishop to Antibodies, Neoplasm
This is a "connection" page, showing publications Michael R. Bishop has written about Antibodies, Neoplasm.
Connection Strength
0.022
-
A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display. Blood. 2009 Nov 12; 114(20):4494-502.
Score: 0.022